The in vivo expansion and persistence of adoptively transferred CD8+ T cells are important determinants of antitumor responses (4–7), whereas the immunosuppressive tumor microenvironment limits the trafficking and effector function of infused T cells (8–10). Here, CD8A is linked to neoplasm.